IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
暂无分享,去创建一个
A. Tall | C. Schindler | S. Gupta | X. Jiang | N. Wang | Sanjay Gupta | A. M. Pablo | N. Wang | X. Jiang | N. Wang
[1] James M. Roberts,et al. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.
[2] E. Furth,et al. Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.
[3] P. Denéfle,et al. Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV , 1996, Science.
[4] A. Daugherty,et al. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[5] G. Hansson,et al. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.
[6] D. L. Fletcher,et al. Immunologic basis of transplant-associated arteriosclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] Michael Ginsberg,et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Gordon,et al. Characterization of an Enhancer Element in the Human Apolipoprotein C-III Gene That Regulates Human Apolipoprotein A-I Gene Expression in the Intestinal Epithelium (*) , 1995, The Journal of Biological Chemistry.
[9] R. Coffman,et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. , 1995, Science.
[10] T. Eberlein,et al. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. C. Smith. AHA president's letter. , 1995, Circulation.
[12] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[13] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] H. Erdjument-Bromage,et al. Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.
[15] G. Homanics,et al. Mild Dyslipidemia in Mice following Targeted Inactivation of the Hepatic Lipase Gene (*) , 1995, The Journal of Biological Chemistry.
[16] Qingbo Xu,et al. Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.
[17] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.
[18] P. Libby,et al. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. , 1995, The Journal of clinical investigation.
[19] J. Qiao,et al. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.
[20] H. Winn,et al. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. , 1994, Transplantation.
[21] R. Ross. The role of T lymphocytes in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Nathan,et al. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.
[23] W. Paul,et al. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.
[24] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[25] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[26] R. Alexander,et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.
[27] K. Reue,et al. Genetic variation in mouse apolipoprotein A-IV expression is determined pre- and post-transcriptionally. , 1993, Journal of lipid research.
[28] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[29] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[30] R. Zinkernagel,et al. Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.
[31] P. Quesenberry,et al. Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. , 1993, The Journal of clinical investigation.
[32] P. Libby,et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[33] S. Snyder,et al. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. , 1993, The Journal of biological chemistry.
[34] M. Farrar,et al. The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.
[35] J. Darnell,et al. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. , 1992, Science.
[36] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[37] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[38] G. Hansson,et al. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.
[39] G. Hansson,et al. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[40] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[41] P. Baeuerle. The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .
[42] A. Abbas,et al. Cellular and Molecular Immunology , 1991 .
[43] L. Fong,et al. Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma. , 1990, The Journal of biological chemistry.
[44] G. Bondjers,et al. Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. , 1990, Biochimica et biophysica acta.
[45] G. Gabbiani,et al. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.
[46] G. Hansson,et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.
[47] P. Libby,et al. Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[48] R. Williams,et al. Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.
[49] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[50] G. Gabbiani,et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.
[51] A. Tall,et al. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. , 1981, The Journal of biological chemistry.
[52] C. W. Adams,et al. Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins. , 1967, The Journal of pathology and bacteriology.
[53] M. Friedman,et al. Resolution of Aortic Atherosclerotic Infiltration in the Rabbit by Phosphatide Infusion.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.